Search results
Results from the WOW.Com Content Network
Tullio Simoncini (born 1951 died 20 May 2024) is a former Italian physician known for alternative medicine advocacy. He is known for the claim that cancer is caused by the fungus Candida albicans, and has argued that cancer is a form of candida overgrowth.
Sodium bicarbonate (or baking soda) – the chemical compound with the formula Na HCO 3, sometimes promoted as cure for cancer by alternative medical practitioners such as Tullio Simoncini. According to the American Cancer Society: "evidence also does not support the idea that sodium bicarbonate works as a treatment for any form of cancer.
Hoxsey Therapy or Hoxsey Method is an alternative medical treatment promoted as a cure for cancer.The treatment consists of a caustic herbal paste for external cancers or a herbal mixture for "internal" cancers, combined with laxatives, douches, vitamin supplements, and dietary changes.
Baking soda can help reduce your risk of cancer A 2020 minireview suggested that baking soda might have anticancer properties but called for a large-scale clinical trial.
As tempting as it is to pin your hopes on a single supplement to prevent or cure cancer, the experts caution against them. "This is a big area for profit-driven misinformation," Kamath says.
Baking soda or sodium bicarbonate, is commonly used in baking to help breads and other baked goods rise, says Melissa Prest, D.C.N., R.D.N., national media spokesperson for the Academy of ...
The purported cure implied a critique of modern science and an appreciation for the simple wisdom of simple people. "They say that common baking soda will cure the disease," he continued, "that they have cured it with it, that they have no deaths up there at all; they use common baking soda, which cures the disease." [94]
Most alternative cancer treatments have not been tested in proper clinical trials. Among studies that have been published, the quality is often poor. A 2006 review of 196 clinical trials that studied unconventional cancer treatments found a lack of early-phase testing, little rationale for dosing regimens, and poor statistical analyses. [11]